Skip to main content

Showing results for Research Findings

IU cancer researchers refining colorectal cancer classification, identifying new targets for treatment using cutting-edge, single-cell technology

Analyzing nearly 500,000 single cells, researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are refining how to classify colorectal cancer and identify new targets to develop effective therapies.

IU School of Medicine  |  May 23, 2022

Statewide study shows COVID-19 antibodies last longer in children than adults, but diminish over time

Indiana University School of Medicine researchers are sharing the results of a study about how immunity to COVID-19 can develop and change over time.

IU School of Medicine  |  Apr 28, 2022

Translational research leader spearheads effort to change kidney function calculation to remove racial variables

After a year of work to bring balance to an equation that measures kidney function by removing racial variables, Sharon Moe, MD, associate dean for clinical and translational medicine and director of the Division of Nephrology for Indiana University School of Medicine, is celebrating a nationally adopted change in how the glomerular filtration rate (GFR) is being calculated to improve patient lives.

Researchers investigate connection between loss of motivation and Alzheimer’s disease progression

Researchers are studying why neuropsychiatric symptoms, such as apathy and irritability, appear in most Alzheimer’s disease patients before the onset of memory loss.

IU School of Medicine  |  Apr 25, 2022

Study: Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood cancers

Using the nation’s largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID.

IU School of Medicine  |  Apr 04, 2022

Researchers discover new information about amyloid filaments in neurodegenerative diseases

Experts at Indiana University School of Medicine have helped identify that a common protein found in neurodegenerative diseases forms amyloid filaments in an age-dependent manner without a connection to disease.

IU School of Medicine  |  Mar 28, 2022

Researchers discover intake of FDA-approved drug modulates disease progression in Alzheimer’s disease model

Indiana University School of Medicine researchers found that niacin limits Alzheimer’s disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic approaches to the disease.

IU School of Medicine  |  Mar 23, 2022

Researchers studying ways to ease asthma symptoms caused by seasonal allergies

Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma. Their findings were recently published in Science Immunology.

Christina Griffiths  |  Mar 21, 2022

IU School of Medicine-led study shows human induced pluripotent stem cells improve visual acuity, vascular health

Researchers are investigating novel regenerative medicine approaches to better manage vascular health complications from type 2 diabetes that could someday support blood vessel repair in the eye among diabetic patients with early retinal vascular dysfunction.

IU School of Medicine  |  Mar 10, 2022

IU School of Medicine study could lead to new treatment for people with asthma, food allergies

Researchers at Indiana University School of Medicine Department of Microbiology and Immunology have made an important new discovery about how a particular molecule could improve lung function for people with asthma and food allergies.

Christina Griffiths  |  Feb 21, 2022